Alemtuzumab induction combined with reduced maintenance immunosuppression is associated with improved outcomes after lung transplantation: A single centre experience.

Alberto BenazzoStefan SchwarzMoritz MuckenhuberThomas SchweigerGabriela MuraközyBernhard MoserJosé Matilla SigüenzaGyörgy LangShahrokh TaghaviWalter KlepetkoKonrad HoetzeneckerPeter JakschCristopher Lambers

Published in: PloS one (2019)

Alemtuzumab induction therapy followed by reduced maintenance immunosuppression is associated with a better kidney function compared to no induction and ATG. Survival rate as well as freedom from ACR and CLAD were comparable between alemtuzumab and ATG.

Keyphrases

extracorporeal membrane oxygenation
mesenchymal stem cells
free survival
bone marrow
chemotherapy induced